Nymox showing price weakness

Nymox Pharmaceutical  {NASDAQ: NYMX} has fallen over 50% in the last six weeks on no negative news!

This is despite recent large purchases of shares by director James Robinson..

Nymox Pharmaceutical  {NASDAQ: NYMX} share price has been surprisingly weak in the last month, having more than halved in value since the 15th December.


This is quite surprising when you take into account the recent share purchases in the market by director Robinson, investing substantial sums of money at an average of around $2.60 – $2.80.


The company have not released any negative news to justify such a drop, and in fact the price was


You do have to wonder where the price would be today but for his substantial purchases!